Abstract:As a continuation of our efforts directed towards the development of natural anti-diabetic cataract agents, gigantol was isolated from Herba dendrobii and was found to inhibit both aldose reductase (AR) and inducible nitric oxide synthase (iNOS) activity, which play a significant role in the development and progression of diabetic cataracts. To improve its bioefficacy and facilitate use as a therapeutic agent, gigantol (compound 14f) and a series of novel analogs were designed and synthesized. Analogs were formulated to have different substituents on the phenyl ring (compounds 4, 5, 8, 14a-e), substitute the phenyl ring with a larger steric hindrance ring (compounds 10, 17c) or modify the carbon chain (compounds 17a, 17b, 21, 23, 25). All of the analogs were tested for their effect on AR and iNOS activities and on D-galactose-induced apoptosis in cultured human lens epithelial cells. Compounds 5, 10, 14a, 14b, 14d, 14e, 14f, 17b, 17c, 23, and 25 inhibited AR activity, with IC50 values ranging from 5.02 to 288.8 μM. Compounds 5, 10, 14b, and 14f inhibited iNOS activity with IC50 ranging from 432.6 to 1188.7 μM. Compounds 5, 8, 10, 14b, 14f, and 17c protected the cells from D-galactose induced apoptosis with viability ranging from 55.2 to 76.26%. Of gigantol and its analogs, compound 10 showed the greatest bioefficacy and is warranted to be developed as a therapeutic agent for diabetic cataracts.

Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents.

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

The Synthesis and Biological Evaluation of Novel Danshensu–cysteine Analog Conjugates As Cardiovascular-Protective Agents

Synthesis, biological evaluation, and molecular docking studies of xanthone sulfonamides as ACAT inhibitors.

Design, Synthesis and Pharmacological Evaluation of (E)-3,4-dihydroxy Styryl Sulfonamides Derivatives As Multifunctional Neuroprotective Agents Against Oxidative and Inflammatory Injury.

Synthesis and Biological Evaluation of Novel Gigantol Derivatives as Potential Agents in Prevention of Diabetic Cataract

Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives to Reverse Mutant Crystallins Induced Protein Aggregation.

Synthesis and Antihypertensive Activity Evaluation in Spontaneously Hypertensive Rats of Lacidipine Analogues

Synthesis and Evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides As Potent Carbonic Anhydrase Inhibitors.

Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives

Synthesis and anti-inflammatory activity of p-(sulfamyl) benzylidene-linked heterocyclic ketone derivatives

Synthesis, Biological Evaluation, and Computational Studies of Schiff's Base Derivatives of 4‐(4‐Amino‐5‐mercapto‐4H‐1,2,4‐triazol‐3‐yl)benzenesulfonamide as Cathepsin B Inhibitors

Synthesis and Anti-cataract Activity of a Novel Peroxidase Mimetics

Design, synthesis and biological evaluation of novel ligustrazinylated derivatives as potent cardiovascular agents

Identification, Synthesis and Photo-protection Evaluation of Arylthiazole Derivatives As a Novel Series of Sunscreens.

Cinnamaldehyde hydrazone derivatives as potential cathepsin B inhibitors: parallel in-vitro investigation in liver and cerebrospinal fluid

Synthesis and Acrosin Inhibitory Activity of Substituted 4-Amino-n-(diaminomethylene) Benzenesulfonamide Derivatives

Synthesis, Molecular Docking Studies and Biological Evaluation of Thiazolyl Hydrazone Derivatives of Chromone-3-carbaldehyde as Potent Anti-Oxidant and Anti-Inflammatory Agents

Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents.

Synthesis and Biological Evaluation of Novel Dimethyl[1,1 '-Biphenyl]-2,2 '-Dicarboxylate Derivatives Containing Thiazolidine-2,4-Dione for the Treatment of Concanavalin A-Induced Acute Liver Injury of Balb/C Mice

Asymmetric Synthesis And Evaluation Of Danshensu-Cysteine Conjugates As Novel Potential Anti-Apoptotic Drug Candidates